Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Stealth AXiS™ Initiates European Clinical Cases: Medtronic plc launched European clinical use of its Stealth AXiS™ surgical system at the Royal National Orthopaedic Hospital, integrating AI planning and navigation into complex revision spine procedures.
• AI Cartilage MRI Predicts Knee Arthroplasty: A study highlighted by Healio Orthopedics revealed that automated deep-learning cartilage segmentation from knee MRI matches expert manual analysis in predicting future total knee replacement.
• EU Trilogue Advances “MDR 2.0” Reforms: BONEZONE detailed European Union legislative negotiations to ease MDR 2017/745 burdens, proposing Well-Established Technology (WET) status for intramedullary nails and eliminating 5-year recertification cycles.
• MicroPort EVOLUTION® AM BIOFOAM® Cleared: MicroPort Orthopedics, Inc. secured FDA 510(k) clearance (K253728) for its EVOLUTION® AM BIOFOAM® 3D-printed porous tibial component for cementless knee reconstruction.
• Osseus Pisces-SC Standalone Cervical Cleared: Osseus Fusion Systems, LLC obtained FDA 510(k) clearance (K261882) for its Pisces-SC zero-profile standalone cervical interbody fusion system.

DAILY ANNOUNCEMENTS BY CATEGORY

Surgical Robotics, AI & Navigation

Medtronic plc — Medtronic Initiates First European Clinical Procedures with Stealth AXiS™ Surgical System

• Summary: Medtronic announced the first clinical procedures utilizing the Stealth AXiS™ surgical system across Europe, marking a key milestone in expanding its AiBLE™ smart spine ecosystem. Initial cases performed at the Royal National Orthopaedic Hospital (RNOH) in the United Kingdom included complex revision spine reconstructions, demonstrating how integrated AI-driven preoperative planning, real-time optical tracking, and robotic navigation assist surgeons through distorted anatomical landmarks and preexisting instrumentation.
• Key Details:
  • Device/System Name: Stealth AXiS™ Surgical System (AiBLE™ Smart Ecosystem)
  • Status: European Clinical Initiation & Regional Rollout
  • Clinical Significance: Enhances surgical precision, screw trajectory accuracy, and operative efficiency during technically demanding revision and deformity spinal procedures while minimizing radiation exposure and mitigating mechanical revision risk.
• Original Source: OrthoSpineNews

Joint Reconstruction

Paracelsus Medical University — AI-Driven MRI Cartilage Segmentation Matches Human Precision in Predicting Knee Arthroplasty Risk

• Summary: A landmark clinical imaging study led by Dr. Felix Eckstein at Paracelsus Medical University demonstrated that fully automated, deep-learning-based cartilage segmentation from knee MRI predicts surgical progression to total knee replacement at least as accurately as time-intensive manual expert segmentation. The automated 3D morphometric pipeline quantifies focal cartilage loss and denudation across femoral and tibial subregions, establishing an objective imaging biomarker for osteoarthritis progression.
• Key Details:
  • Device/System Name: Automated Deep-Learning MRI Cartilage Segmentation Pipeline
  • Status: Peer-Reviewed Clinical Imaging Evidence
  • Clinical Significance: Provides a scalable, validated surrogate imaging endpoint for clinical trials of disease-modifying osteoarthritis drugs (DMOADs) and enables predictive risk stratification to assist orthopaedic surgeons in timing total joint arthroplasty.
• Original Source: Healio Orthopedics

Corporate, M&A & Regulatory

European Union Regulatory Affairs — European Union Enters Trilogue on “MDR 2.0” Reforms to Relieve Orthopaedic Regulatory Burden

• Summary: The European Commission, European Parliament, and European Council have entered trilogue negotiations on “MDR 2.0” legislative reforms aimed at streamlining Regulation (EU) 2017/745 for musculoskeletal devices. Key proposals include expanding the Well-Established Technology (WET) classification to include orthopaedic intramedullary nails and bone void fillers to reduce clinical data burdens, cutting Periodic Safety Update Report (PSUR) frequency in half, and eliminating the burdensome 5-year CE recertification cycle in favor of continuous post-market surveillance.
• Key Details:
  • Device/System Name: Regulation (EU) 2017/745 “MDR 2.0” Reform Framework
  • Status: EU Trilogue Legislative Negotiations
  • Clinical Significance: Alleviates acute regulatory bottlenecks and excessive recertification costs that have threatened European device availability, accelerating patient access to proven orthopaedic implants and aligning EU conformity assessment closer to FDA paradigms.
• Original Source: BONEZONE

RECENTLY INDEXED FDA 510(k) & PMA CLEARANCES — ORTHOPAEDIC

Note: The openFDA database typically indexes clearances 2–4 weeks after the official decision date. Dates shown reflect the FDA decision date, not the indexing date.